{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-026182","form_type":"8-K","ticker":null,"cik":"0001504167","company_name":"TREX WIND-DOWN, INC.","filed_at":"2023-09-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.127375+00:00","generated_at":"2026-06-10T14:40:36.084993+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NYSE American accepts Timber's plan to regain listing compliance; extension to Dec 2024","bullets":["NYSE American granted extension until December 28, 2024 for Timber to comply with equity requirements.","As of March 31, 2023, Timber reported stockholders' deficit of $1.3M; needs $2M-4M equity.","Common stock (TMBR) continues trading with '.BC' (below compliance) designation.","Failure to progress or meet deadline could result in delisting; pending merger with LEO Pharma may also lead to delisting.","The notice does not affect business operations or SEC reporting requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-026182","json":"https://secwatch.observer/filing/0001437749-23-026182.json","markdown":"https://secwatch.observer/filing/0001437749-23-026182.md","text":"https://secwatch.observer/filing/0001437749-23-026182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1504167/000143774923026182/0001437749-23-026182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1504167/000143774923026182/tmbr20230914_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T14:40:36.084993+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"890d2b4f32e2b70016e72c2c68eec40e5bb61d29","claim":"TREX WIND-DOWN, INC. received a nyse_american extension granted notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).","evidence_excerpt":". ☐ ​ Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously announced, on June 28, 2023, the NYSE American LLC (the “NYSE American”) notified Timber Pharmaceuticals, Inc. (the “Company”) that it no longer complied with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide (the “Deficiency Letter”). Section 1003(a)(i) of the NYSE American Company Guide requires a listed company’s stockholders’ equity be at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1504167/000143774923026182/0001437749-23-026182-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nyse american"},{"label":"Notice","value":"extension granted"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"1003(a)(i), 1003(a)(ii)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}